Found 5 matching trials
A Study of a Thyroid Hormone Receptor Beta Isoform (THRΞ²) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH) PHASE2 The primary objective of this trial is to evaluate the dose-dependent and c...
Show More Location
Arizona Liver Health
Learn More & Join Trial
ECC4703 Food Effect and Relative Bioavailability Study in Healthy Adult Participants PHASE1 This is a Phase I, open-label, randomized, single-dose, 2-part study design...
Show More Location
CMAX Clinical Research Pty Ltd
Learn More & Join Trial
MIST (Metabolic Intervention With Semaglutide and THR-Ξ² Therapy) Trial PHASE2 The primary objective of this trial is to evaluate the effect of oral ECC47...
Show More Status
Active Not Recruiting
Location
Central Research Associates - Flourish - PPDS
Learn More & Join Trial
Study of ECC4703 With Sulfasalazine and Pitavastatin PHASE1 Non-alcoholic fatty liver disease is a chronic, serious, life-threatening, ...
Show More Location
Nucleus Network Pty Ltd
Learn More & Join Trial
FTIH of ECC4703 in Healthy Volunteers EARLY_PHASE1 This is a Phase 1, randomized, double-blind, placebo-controlled, single asc...
Show More Location
Eccogene Investigational Site
Learn More & Join Trial